Here are five key points:
1. The surgery performed by Dr. Carter was part of the SUN trial, which has enrolled 120 patients to gain FDA approval to sell the NUsurface device.
2. NUsurface is designed to decrease and alleviate pain, delay knee replacement surgery and improve level activity in patients.
3. The implant device is being used as an investigational treatment for patients with persistent knee pain following medial meniscus surgery.
4. The Orthopedic Clinic Association is a one-stop resource for patients looking to see experts in orthopedics and sports medicine.
5. Active Implant develops orthopedic implant solutions that complement the natural biomechanics of the musculoskeletal system.
More articles on orthopedics:
Steadman Philippon Research Institute, Smith & Nephew host knee symposium: 4 takeaways
Orthopedic surgeon to know: Dr. Paul Dimond of Cape Cod Hospital
Dr. Michael Kuhn performs CT’s 1st MACI knee cartilage procedure: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.